IMMUNITYBIO, INC.

Transcripts ImmunityBio, Inc.

Equities

IBRX

US45256X1037

Market Closed - Nasdaq Other stock markets 04:00:00 2024-06-11 pm EDT			5-day change	1st Jan Change
5.96 ^USD	-4.49%		-3.09%	+18.73%

May. 09	ImmunityBio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
May. 07	ImmunityBio Shares Rise After Completion of Drug Substance Manufacturing for Cancer Treatment	MT

Transcripts

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Transcript : ImmunityBio, Inc. - Special Call	Apr. 26
Transcript : ImmunityBio, Inc. - Special Call	23-09-21
Transcript : NantKwest, Inc. Presents at 39th Annual JPMorgan Virtual Healthcare Conference, Jan-13-2021 05:20 AM	21-01-13
Transcript : ImmunityBio, Inc., NantKwest, Inc. - M&A Call	20-12-21
Transcript : NantKwest, Inc. - Special Call	20-05-27
Transcript : NantKwest, Inc. Presents at 38th Annual J.P Morgan Healthcare Conference, Jan-14-2020 11:00 AM	20-01-14
Transcript : NantKwest, Inc. - Special Call	19-12-02
Transcript : NantKwest, Inc. - Analyst/Investor Day	19-01-08
Transcript : NantKwest, Inc. - Analyst/Investor Day	18-01-09

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019

Replicate our performance

fermer